THE STUDY OF PATIENT’S INFORMING QUALITY ON RATIONAL DRUG USE
DOI:
https://doi.org/10.54890/.v3i3.1012Abstract
Abstract: the article focuses the quality of patient’s informing on the rational druguse (RDU). As a result of the study it was found that, according to the patients opinion, the informingquality is generally satisfactory, but there are disadvantagesin terms of information providing on side effects and drug storage. It was also marked a low level of therapeutic communication skills of physicians and a high degree of patient adherence to drug therapy.
Keywords:
rational drug use, compliance, adherence, therapeutic communication, pharmacotherapy, drug therapy.References
1. Политика в области информации о лекарствен-ных средствах в странах центральной и восточ-ной Европы и в Новых Независимых Государствах – Отчет о рабочем совещании ВОЗ. Хиллеред, Да-ния, 27.03–02.04.1996.
2. Чучалин А.Г., Шухов В.С., ХарперДж.Р. Формуляр лекарственных средств: проблемные вопросы. //Русский медицинский журнал. 1999 г, № 12, С. 535-542. http://www.rmj.ru/articles_1912.htm
3. Декларации о правах пациентов в России (приня-та на Первом Всероссийском конгрессе пациен-тов 28 мая 2010 года в Москве). Москва, 2010. http://www.patients.ru/en/patients/rights-declarations
4. De Vries T.P. G.M., Henning R.H., Hogerzeil H.V., Fresle D.A. Guide to Good Prescribing. WHO, Gene-va, 1995.
5. Wubben DP, Vivian EM. Effects of pharmacist outpa-tient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008 Apr; 28(4):421-36. doi: 10.1592/phco.28.4.421. Review.
6. Oenning D, Oliveira BV, Blatt CR. Patient awareness about drugs prescribed after medical appointment and prescription [Article in Portuguese].Cien Saude Colet. 2011 Jul;16(7):3277-83.
7. Celik E., Nazh M., Encan M., Clark P. Review: Fac-tors affecting rational drug use (RDU), compliance and wastage. //Turk J. Pharm. Sci. 10 (1), 15-170, 2013.
8. Sankaravadivu T., Samjeevakumar E., Bhavya E.A Prospective Study on Rational Drug Use and The Es-sential Drug Concept. //International Journal of Re-search in Pharmaceutical and Biomedical Sciences. - Vol. 2 (2) Apr – Jun 2011.
9. World Health Organization. Medicines: rational use of medicines. Fact sheet no 338. 2010. Available from: http://www.who.int/mediacentre/factsheets /fs338/en/index.html.Accessed September 13, 2012.
10. Gazmararian J.A., Kripalani S., Miller M.J., Echt K.V., Ren J., Rask K., Factors associated with medi-cation refill adherence in cardiovascular-related diseases Journal of General Internal Medicine, De-cember 2006, Volume 21, Issue 12, pp 1215-1221.
11. Sencan N.M, Wertheimer A.I, Levine C.B. What de-termines the duration of patient medication compli-ance in patients with chronic disease: are we look-ing in the wrong place? Southern Med Review 4(2), 50-54, 2011.
12. Vermeire E., Hearnshaw H., Van Royen P. and Den-ekens J. Patient adherence to treatment: three dec-ades of research. A comprehensive review (REVIEW ARTICLE). //Journal of Clinical Pharmacy and Therapeutics (2001) 26, 331-342.
13. Carol D. Tamparo, Wilburta Q. Lindh. Therapeutic Communications for Health Care Paperback – July 24, 2007.
14. Baumann M., Baumann C., Le Bihan E., Chau N. How patients perceive the therapeutic communica-tions skills of their general practitioners, and how that perception affects adherence: use of the TCom-skill GP scale in a specific geographical area. //BMC Health Services Research. 2008, 8:244.
15. Cegala D.J., Marinelli T., Post D. The Effects of Pa-tient Communication Skills Training on Compliance. Arch Fam Med. 2000; 9:57-64.